glp-1 weight loss drug news today 2025 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom New GLP-1 alternative, eloralintide, leads

Conversely, equivalent residues in GCGR (I194 2.67b and S297 ECL2 ) are unable to form these hydrogen bonds

The Semaglutide Treatment Effect in People with Obesity and Heart Failure with Preserved Ejection Fraction and Diabetes Mellitus (STEP-HFpEF DM) trial demonstrated that semaglutide significantly reduced body weight and improved HF-related symptoms and physical limitations in people with obesity-related HF with preserved ejection fraction and type 2 diabetes mellitus [93]

Balancing these tangible costs against theoretical aspiration risks reinforces the need for pragmatic, patient-centered management rather than blanket cancellation policies

Common Side Effects Most people who take GLP-1 medications experience mild digestive symptoms that often improve over time: Nausea: The most frequently reported side effect Diarrhea: Usually temporary as your body adjusts Stomach upset: Can be reduced by eating smaller meals Loss of appetite: This is actually part of how the medication works Serious but Rare Side Effects Some side effects are uncommon but require immediate medical attention: Thyroid tumors: Reported in less than 1 percent of patients Gallbladder problems: Including gallstones in some patients Severe stomach pain: Could indicate pancreatitis Kidney problems: Especially if you become dehydrated Patients should discuss all potential risks with their healthcare provider before starting any GLP-1 medication

This narrative review aims to explore the role of GLP-1 RAs in weight management and cardiovascular health, and how they affect metabolic parameters such as blood glucose, lipid profiles, and blood pressure

These injections, combined with personalized care, help achieve sustainable results